{"id":"W4321201232","doi":"10.1016/j.obmed.2023.100483","title":"Tirzepatide, a new class of incretin-based drug for diabetes","year":2023,"lang":"en","type":"article","venue":"Obesity Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration; Juvenile Diabetes Research Foundation Canada; Eli Lilly and Company","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Obesity; Weight loss; Internal medicine; Type 2 diabetes; Pediatrics; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004611744,0.0001666425,0.0005291453,0.0002801083,0.00004434102,0.000003393841,0.0001008094,0.00003930667,0.0002437394],"category_scores_gemma":[0.0003604435,0.00012506,0.0001157151,0.0004792534,0.0001049175,0.00003035182,0.00004094388,0.0000636862,0.00007268378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004754643,"about_ca_system_score_gemma":0.00008222829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000125077,"about_ca_topic_score_gemma":0.00003116568,"domain_scores_codex":[0.9987844,0.00002279612,0.0002960365,0.0002413605,0.0003343904,0.0003210268],"domain_scores_gemma":[0.9989136,0.0003498916,0.0001094178,0.0003372771,0.00009543339,0.0001943797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001807745,0.0002991243,0.3881575,0.001323803,0.0003483146,0.00001979372,0.0003641562,0.00001378626,0.005070615,0.0009719157,0.5887896,0.01446057],"study_design_scores_gemma":[0.03218878,0.004473273,0.5394224,0.003046698,0.003327285,8.426045e-7,0.0005334619,0.01227598,0.05726694,0.002611946,0.3442436,0.0006088001],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738989,0.0002426174,0.0001648492,0.01811837,0.0002549273,0.001078375,0.00001300083,0.0002215135,0.006007459],"genre_scores_gemma":[0.9755381,0.00004811234,0.001131214,0.001809699,0.0003628596,0.00007278224,0.0004080509,0.00003272827,0.02059641],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.244546,"threshold_uncertainty_score":0.5099798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01997206219297698,"score_gpt":0.2746783828237384,"score_spread":0.2547063206307614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}